Canterbury DHB


Acquired CMV Infection - Treatment

For general information about CMV, see UpToDate website.

In This Section

Clinical Features



Clinical Features

These are extremely variable.


The diagnostic test currently recommended is Q-PCR for CMV DNA on plasma and white blood cells. The results are now reported in International Units per litre (IU/L).

Take 5 mL blood into EDTA (mauve top) tube. This will detect CMV viral DNA, and give a measure of the viral load present. Repeat testing can be used to monitor progression or the effectiveness of treatment.



Note: Oral valganciclovir is also available. For more information, see the valganciclovir Data Sheets on Medsafe.


Foscarnet may be used in place of ganciclovir when ganciclovir marrow suppression is present:

The major complication of foscarnet is electrolyte disturbance which needs to be checked daily, including magnesium and phosphate.

For more information about foscarnet, refer to the Data Sheets on Medsafe.

About this Canterbury DHB document (5030):

Document Owner:

Andrew Butler (see Who's Who)

Last Reviewed:

May 2021

Next Review:

May 2023


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5030